SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$0.50
-0.05 (-9.31%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+7,165.4% upside
Low Target
$26.81
Average Target
$36.24
High Target
$52.45
Current Price
$0.50
Current
$0.50
$0.50
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Scenario Analysis
Bear Case
$26.81
5,274.9%
Low target
Base Case
$36.24
+7,165.4%
Avg target
Bull Case
$52.45
+10,415.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$22.36
-97.8% from high
52-Week Low
$0.46
+8.3% from low
Target vs 52W High
$36.24
+62.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +22.4% |
| AMGN | Hold | 44 | 48% | $190.87 | -41.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +179.9% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +0.3% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -64.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -21.7% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.6% |